跳至主要内容
临床试验/NL-OMON26611
NL-OMON26611招募中不适用

Improving clinical management of colon cancer through CONNECTION, a nation-wide Colon Cancer Registry and Stratification effort

Alpe d'huzes0 个研究点目标入组 262 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
262

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients are eligible when they meet the following criteria:
  • Patient is able and willing to provide written informed consent for the CONNECTION- study
  • Informed consent signed for PLCRC components ‘clinical data’ and ‘future studies’
  • MSS based on pre-treatment biopsy by IHC
  • Fit to undergo neoadjuvant chemotherapy with capecitabine + oxaliplatin and subsequent surgery judged by the primary treating physician
  • Adequate bone marrow, liver and renal function

排除标准

  • Any other malignant disease within the preceding 5 years apart from non-melanomatous skin cancer, carcinoma in situ and early stage disease with a recurrence risk of less than 5%
  • Colonic obstruction that cannot be defunctioned by a stoma
  • Pregnant or lactating women

研究者

发起方
Alpe d'huzes

相似试验

A study on the response to neoadjuvant chemotherapy... | 临床试验